New research finds chronic pain is five times more common in patients with Parkinson’s disease compared to age-matched ...
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
10h
Hosted on MSNFDA Approves Adaptive Deep Brain Stimulator for Parkinson's DiseaseThe FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...
New research shows people in specific Polynesian communities have a much higher rate of a form of Parkinson’s disease ...
There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...
The BrainSense Adaptive technology is an enhancement to Medtronic’s Percept DBS neurostimulators. The advancement personalizes therapy based on a patient’s brain activity in real-time. Therapy ...
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...
New findings from scientists from the Carney Institute for Brian Science explain memory limits and shed light on ...
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available nationwide in the next few months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results